Form 4: BioCardia CEO Peter Altman Increases Stake in Company

BioCardia's President and CEO, Peter Altman, recently purchased additional shares of the company's common stock, increasing his beneficial ownership.

Summary

• Peter Altman, the President and CEO of BioCardia, Inc., has increased his holdings of the company's common stock.
• On May 20, 2025, Altman purchased 1,600 shares at a weighted average price of $2.08 per share, in a range of $1.97 to $2.22.
• On May 22, 2025, he acquired an additional 700 shares at a weighted average price of $1.89 per share, in a range of $1.87 to $1.96.
• Following these transactions, Altman's total direct ownership amounts to 141,666 shares.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the CEO's increased investment in the company, which can be seen as a vote of confidence. However, it's a single event and doesn't guarantee future performance.

Positives

• The CEO's purchase of additional shares could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Insider buying is often viewed as a positive signal, suggesting that a company's leadership believes the stock is undervalued. However, it's important to consider the overall context and not rely solely on insider transactions when making investment decisions.

Stakeholder Impact

• Shareholders may view the CEO's stock purchase positively.

Key Dates

Keywords

BioCardia, BCDA, Peter Altman, Insider Trading, Stock Purchase, Beneficial Ownership, SEC Form 4